We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

964 hedge funds and large institutions have $48B invested in Thermo Fisher Scientific in 2015 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 336 increasing their positions, 398 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $260M | Put options by funds: $149M

24% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 67

12% more funds holding in top 10

Funds holding in top 10: 6775 (+8)

5% more capital invested

Capital invested by funds: $45.5B → $48B (+$2.45B)

0% more funds holding

Funds holding: 960964 (+4)

0.79% less ownership

Funds ownership: 90.96%90.17% (-0.79%)

16% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 398

Holders
964
Holders Change
+4
Holders Change %
+0.42%
% of All Funds
25.69%
Holding in Top 10
75
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+11.94%
% of All Funds
2%
New
83
Increased
336
Reduced
398
Closed
67
Calls
$260M
Puts
$149M
Net Calls
+$112M
Net Calls Change
+$59.7M
Name Holding Trade Value Shares
Change
Change in
Stake
KBC Group
401
KBC Group
Belgium
$4.87M -$3.62M -28,113 -44%
LWCA
402
Locust Wood Capital Advisers
New York
$4.84M +$4.64M +35,995 New
AB
403
AT Bancorp
Iowa
$4.75M +$157K +1,215 +4%
JGUA
404
John G. Ullman & Associates
New York
$4.58M -$226K -1,750 -5%
Bank of Nova Scotia
405
Bank of Nova Scotia
Ontario, Canada
$4.58M -$263K -2,043 -6%
GLRA
406
Gerald L. Ray & Associates
Texas
$4.55M +$19.3K +150 +0.4%
BCA
407
Bernzott Capital Advisors
California
$4.54M -$1.03M -7,990 -19%
IAM
408
Impax Asset Management
New Hampshire
$4.52M +$466K +3,615 +12%
BCM
409
BTC Capital Management
Iowa
$4.46M -$25.5K -198 -0.6%
LSA
410
L & S Advisors
California
$4.46M +$74.1K +575 +2%
FFSOTS
411
Fiduciary Financial Services of The Southwest
Texas
$4.43M -$139K -1,075 -3%
PPSG
412
Princeton Portfolio Strategies Group
New Jersey
$4.42M +$576K +4,465 +16%
FM
413
Foster & Motley
Ohio
$4.39M -$1.58M -12,278 -27%
BTNA
414
Bremer Trust National Association
Minnesota
$4.29M -$180K -1,395 -4%
N
415
Nuveen
North Carolina
$4.21M -$15K -116 -0.4%
CCT
416
Country Club Trust
Missouri
$4.18M -$9.67K -75 -0.2%
DBT
417
Dubuque Bank & Trust
Iowa
$4.11M +$386K +2,993 +11%
PA
418
Profund Advisors
Maryland
$4.1M +$13.3K +103 +0.3%
Canada Pension Plan Investment Board
419
Canada Pension Plan Investment Board
Ontario, Canada
$4.07M -$19.9M -154,166 -84%
SLI
420
Sumitomo Life Insurance
Japan
$4.04M -$415K -3,222 -10%
CANY
421
Caxton Associates (New York)
New York
$4.03M +$3.87M +30,000 New
DM
422
Diker Management
New York
$4.02M +$3.6M +27,950 +1,433%
CIBC Private Wealth Group
423
CIBC Private Wealth Group
Georgia
$3.96M +$65.9K +511 +2%
BC
424
Barnett & Company
Tennessee
$3.89M -$144K -1,115 -4%
ICM
425
ICC Capital Management
Florida
$3.88M +$3.73M +28,900 New

TMO Hedge Fund Activity: Q1 2015 in Review

964 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2015, worth a combined $48B — up 5.4% from $45.5B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new TMO positions and 67 closed out — a net gain of 16 holders — while 336 added to existing stakes and 398 trimmed.

The largest buyer was Capital World Investors, adding an estimated $324M. The largest seller was Glenview Capital Management, cutting an estimated $577M.

  • 964 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2015, up from 960 in Q4 2014.
  • Funds reported $48B of Thermo Fisher Scientific stock for Q1 2015, up 5.4% quarter-over-quarter.
  • 83 funds opened new Thermo Fisher Scientific positions in Q1 2015 and 67 closed out, a net change of +16 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2015 was Capital World Investors, an estimated $324M added.
  • The largest Thermo Fisher Scientific seller in Q1 2015 was Glenview Capital Management, an estimated $577M sold.

Based on aggregated 13F filings for Q1 2015.